Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Opsens Inc
T.OPS
Healthcare
Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR...
) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:OPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Sep 15, 2022 12:35pm
The best tool
I dont think that cardiologist are going to settle for anything less than the best tool in the market and this weekend its going to be common knowledge what the best tool is. Im still buying this is a
...more
(5531)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Sep 15, 2022 11:58am
Weak Market
I guess I should be appreciative of today's market as it gave me an opportunity to add more at $2.96 when I didn't expect it to fall below $3.00. As is obvious, the Canadian market is dwarfed
...more
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(27)
•••
bossu
X
View Profile
View Bullboard History
Post by
bossu
on Sep 15, 2022 11:33am
Another milestone to bring Opaens to a new level...
The global TAVR market is currently estimated at over 200,000 procedures and is expected to reach 400,000 in 2027. The OptoWire has been used in the diagnosis and treatment of over 150,000 patients in
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Sep 15, 2022 11:26am
RE:What we need now
Right now the speculators need to jump ship after that we can only hope for big investors to come in. Nasdaq listing would help but most importantly announcing sales is what is going to drive this
...more
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Comment by
ivebeenthere
on Sep 15, 2022 11:01am
RE:RE:Just two days notice
Same to you Nadia !
(6)
•••
jelliedeeel
X
View Profile
View Bullboard History
Post by
jelliedeeel
on Sep 15, 2022 10:58am
USA Listing
They should apply for a proper US listing, that would open up to a large new investor base.
(25)
•••
Nadia6519
X
View Profile
View Bullboard History
Comment by
Nadia6519
on Sep 15, 2022 10:39am
RE:Just two days notice
Your feeling was right ivebeenthere, congratulations to you and to all longs!
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Sep 15, 2022 10:38am
What we need now
What id like to see now is a declined take over offer at 4$ or 5$. Then let the offers roll in. Enjoy the day everyone
(5531)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Sep 15, 2022 9:17am
RBC
September 15, 2022 Opsens Inc. FDA approval of SavvyWire received slightly ahead of expected timelines TSX: OPS | CAD 2.79 | Outperform | Speculative Risk | Price
...more
(27)
•••
bossu
X
View Profile
View Bullboard History
Post by
bossu
on Sep 15, 2022 8:54am
Cannot be a better timing...and a wishing thinking i dream!
" commented Louis Laflamme, President and Chief Executive Officer of OpSens. "SavvyWire uniquely provides a 3-in-1 solution for stable aortic valve delivery and positioning, continuous
...more
(1486)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Sep 15, 2022 8:51am
an overnight sensation , years in the making
RBC started coverage in November, 2014 when the stock was 59 cents.
(77)
•••
ivebeenthere
X
View Profile
View Bullboard History
Post by
ivebeenthere
on Sep 15, 2022 8:14am
Lift off !
I heard that lift off is scheduled at 9:30 ! Hold on to your hats. Have a nice day everyone !
(310)
•••
ddogold
X
View Profile
View Bullboard History
Post by
ddogold
on Sep 15, 2022 7:50am
TAVR receives
FDA approval . Congrats all .
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 15, 2022 7:01am
New Press Release - OPSENS ANNOUNCES FDA CLEARANCE FOR THE SAVVYWIRE(TM) FOR USE IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PROCEDURES
QUEBEC CITY, Sept. 15, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it has received 510(k) regulatory clearance...
read article.
(3)
•••
WhiteknightA
X
View Profile
View Bullboard History
Post by
WhiteknightA
on Sep 14, 2022 9:24pm
Conference
Any company participating in conferences are generally positive. Especially attending one in America with a market of their size. Hopefully they attract investors or someone to buy them out.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project